3,292
Views
120
CrossRef citations to date
0
Altmetric
Original Research Articles

Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane

, , , , , , & show all
Article: 22614 | Received 15 Aug 2013, Accepted 03 Dec 2013, Published online: 23 Dec 2013

References

  • Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood. 2003; 102: 3483–93.
  • Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol. 2001; 189: 54–63.
  • Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109: 235–42.
  • In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, etal. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003; 102: 1548–9.
  • Kim J, Breunig MJ, Escalante LE, Bhatia N, Denu RA, Dollar BA. Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets. Cytotherapy. 2012
  • Ricciardi M, Malpeli G, Bifari F, Bassi G, Pacelli L, Nwabo Kamdje AH, etal. Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. PLoS One. 2012; 7: e35639.
  • Lian Q, Lye E, Suan Yeo K, Khia Way Tan E, Salto-Tellez M, Liu TM, etal. Derivation of clinically compliant MSCs from CD105+, CD24-differentiated human ESCs. Stem Cells. 2007; 25: 425–36.
  • Lai RC, Choo A, Lim SK. Derivation and characterization of human ESC-derived mesenchymal stem cells. Methods Mol Biol. 2011; 698: 141–50. [PubMed Abstract].
  • Jung Y, Bauer G, Nolta JA. Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells. 2012; 30: 42–7.
  • Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007; 211: 27–35.
  • Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res. 1998; 16: 155–62.
  • Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238: 265–72.
  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, etal. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143–7.
  • Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992; 13: 81–8.
  • Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, etal. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am. 1998; 80: 1745–57. [PubMed Abstract].
  • Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res. 1999; 14: 700–9.
  • Gojo S, Gojo N, Takeda Y, Mori T, Abe H, Kyo S, etal. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res. 2003; 288: 51–9.
  • Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, etal. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000; 164: 247–56.
  • Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000; 61: 364–70. [PubMed Abstract].
  • Kohyama J, Abe H, Shimazaki T, Koizumi A, Okano H, Hata J, etal. Brain from bone: efficient “meta-differentiation” of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation. 2001; 68: 235–44.
  • Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Matsuzaki M, etal. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res. 2000; 89: 189–95.
  • Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999; 100(19 Suppl): 247–56.
  • Sato T, Iso Y, Uyama T, Kawachi K, Wakabayashi K, Omori Y, etal. Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest. 2011; 91: 553–64.
  • Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98: 1076–84.
  • Timmers L, Lim S-K, Arslan F, Armstrong JS, Hoefler IE, Doevendans PA, etal. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2008; 1: 129–37.
  • Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, etal. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010; 4: 214–22.
  • Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010; 38: 215–24.
  • Simons M, Raposo G. Exosomes – vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009; 21: 575–81.
  • Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer. 2009; 9: 40–55.
  • Fishman PH, Atikkan EE. Induction of cholera toxin receptors in cultured cells by butyric acid. J Biol Chem. 1979; 254: 4342–4. [PubMed Abstract].
  • Fujinaga Y, Wolf AA, Rodighiero C, Wheeler H, Tsai B, Allen L, etal. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm. Mol Biol Cell. 2003; 14: 4783–93.
  • Laude AJ, Prior IA. Plasma membrane microdomains: organization, function and trafficking (Review). Mol Membr Biol. 2004; 21: 193–205.
  • Rajendran L, Simons K. Lipid rafts and membrane dynamics. J Cell Sci. 2005; 118: 1099–102.
  • Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, etal. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319: 1244–7.
  • Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo AB, etal. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med. 2011; 9: 47.
  • Lai RC, Arslan F, Tan SS, Tan B, Choo A, Lee MM, etal. Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol. 2010; 48: 1215–24.
  • Sze SK, de Kleijn DP, Lai RC, Tan EKW, Zhao H, Yeo KS, etal. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics. 2007; 6: 1680–9.
  • Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, etal. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics. 2012; 2012: 971907.
  • Lai R, Yeo R, Tan S, Zhang B, Yin Y, Sze S, LGV Chase, Mohan C. Mesenchymal stem cell exosomes: the future MSC-based therapy?. Mesenchymal stem cell therapy. 2013; New York: Humana Press. 39–62.
  • Holmgren J, Lonnroth I, Mansson J, Svennerholm L. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc Natl Acad Sci U S A. 1975; 72: 2520–4.
  • Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, etal. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319: 1244–7.